肝纤维化的常见病因与发病机制

施光峰

施光峰. 肝纤维化的常见病因与发病机制[J]. 实用临床医药杂志, 2005, (7): 1-3,9. DOI: 10.3969/j.issn.1672-2353.2005.07.001
引用本文: 施光峰. 肝纤维化的常见病因与发病机制[J]. 实用临床医药杂志, 2005, (7): 1-3,9. DOI: 10.3969/j.issn.1672-2353.2005.07.001
SHI Guang-feng. Common pathogenies of fibrosis[J]. Journal of Clinical Medicine in Practice, 2005, (7): 1-3,9. DOI: 10.3969/j.issn.1672-2353.2005.07.001
Citation: SHI Guang-feng. Common pathogenies of fibrosis[J]. Journal of Clinical Medicine in Practice, 2005, (7): 1-3,9. DOI: 10.3969/j.issn.1672-2353.2005.07.001

肝纤维化的常见病因与发病机制

详细信息
  • 中图分类号: R575.2 R512.6

Common pathogenies of fibrosis

  • 摘要: 肝纤维化是肝细胞发生坏死或炎症刺激时,肝内纤维结缔组织异常增生的病理过程,进一步发展可引起肝小叶结构改建、假小叶及结节形成,即肝硬化.肝纤维化是慢性肝病重要的病理特征,也是肝硬化发生的前奏和必经中间环节,它是一个缓慢而动态的过程,涉及到细胞、细胞因子、细胞外基质之间一系列复杂的变化[1~3].
  • Friedman S L. Liver fibrosis-from bench to bedside [J]. Journal of Hepatology, 2003, (zk):38.doi: 10.1016/S0168-8278(02)00429-4.
    王宝恩. 肝星状细胞与肝纤维化 [J]. 中华肝脏病杂志, 2000, (4):197.doi: 10.3760/j.issn:1007-3418.2000.04.001.
    沈鼎明. 肝纤维化的发生机制 [J]. 中华肝脏病杂志, 2000, (4):241.doi: 10.3760/j.issn:1007-3418.2000.04.016.
    Bataller R, Brenner D A. Liver fibrosis [J]. Journal of Clinical Investigation, 2005.209.
    Friedman S L, Roll F J, Boyles J. Hepatic lipocytes:the principal collagen-producing cells of normal rat liver Proc Natl [J]. Academic Science, 1985.8681.
    Alcolodo R. Pathogenesis of liver fibrosis [J]. Clinical Science, 1997.103.
    FRIDMAN S L. Molecular mechanisms of hepatic fibrosis and principle of therapy [J]. Journal of Gastroenterology, 1997.424.doi: 10.1007/BF02934504.
    Li D, Fridman S L. Liver fibrogenesis and the role of hepatic stellate cells:new insights and prospects for therapy [J]. Journal of Gastroenterology and Hepatology, 1999, (7):618.doi: 10.1046/j.1440-1746.1999.01928.x.
    Friedman S L. Closing in on the signals of hepatic fibrosis [J]. GASTROENTEROLOGY, 1997.1406.doi: 10.1016/S0016-5085(97)70158-6.
    Benyon R C, Arthur M J. Mechanism of hepatic fibrosis [J]. Journal of Pediatric Gastroenterology and Nutrition, 1998.75.doi: 10.1097/00005176-199807000-00013.
    Gressner A M, Weiskirchen R, Breitkopf K. Roles of TGF-beta in hepatic fibrosis [J]. Frontiers in Bioscience, 2002.793.doi: 10.2741/gressner.
    Arthur M J, Fibrogenesis Ⅱ. Metalloproteinases and their inhibitors in liver fibrosis [J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2000.245.
    Iredale J P. Tissue inhibitors of metalloproteinases in liver fibrosis [J]. International Journal of Biochemistry & Cell Biology, 1997.43.
    Parsons S L, Watson S A, Brown P D. Matrix metalloproteinases [J]. British Journal of Surgery, 1997.160.
    曾仲, 韩本立. 基质金属蛋白酶组织抑制剂的生物学功能 [J]. 国外医学(分子生物学分册), 2000.84.
    Borkakoti N. Matrix metalloproteases:variations on a theme [J]. Progress in Biophysics and Molecular Biology, 1998, (1):73.
    Massova I, Kotra L P, Fridman R. Matrix metalloproteinases:structures, evolution, and diversification [J]. FASEB JOURNAL, 1998.1075.
    Denhardt D T, Feng B, Edwards D R. Tissue inhibitor of metalloproteinases(TIMP, aka EPA):structure, control of expression and biological funtions [J]. Pharmacology & Therapeutics, 1993.329.doi: 10.1016/0163-7258(93)90074-N.
计量
  • 文章访问数:  244
  • HTML全文浏览量:  32
  • PDF下载量:  22
  • 被引次数: 0
出版历程
  • 发布日期:  2005-10-19

目录

    /

    返回文章
    返回
    x 关闭 永久关闭